/Investor DB

CTI Life Sciences Fund L.P. — Full Portfolio

47 tracked investments · listed companies and verified rows first

Zymeworkszymeworks.comin𝕏NASDAQ: ZYMEDec 2014

Zymeworks is a biotechnology company that develops novel therapeutics for patients with difficult-to-treat diseases using its proprietary drug-development platforms and in-house R&D.

BiotechHealthtechVancouver, US

ALI TEHRANI(Executive Officer, Director)inGORDON NG(Executive Officer)NEIL KLOMPAS(Executive Officer)inSURJIT DIXIT(Executive Officer)inDAVID TUCKER(Executive Officer)Paul Moore(Chief Scientific Officer)in

Board seatShermaine Tilley· per SEC Form D

Co-investorsadMare BioInnovationsBrace PharmaHBM Healthcare InvestmentsLumira VenturesNextech InvestWUTIF Capital+1 more

Profound Medicalprofoundmedical.comin𝕏NASDAQ: PROF

Profound Medical develops real-time MRI-guided thermal ultrasound systems for incision-free ablation of abnormal or cancerous tissue.

BiotechDeep TechHealthtechMedical DevicesMississauga

Arun Menawat(CEO and Chairman of the Board)inRashed Dewan(Executive Officer)inMathieu Burtnyk(Chief Operating Officer)inTom Tamberrino(Chief Commercial Officer)

BoardJean-Francois Pariseau(Director)Damian Lamb(Director)

Co-investorsFACIT (Fight Against Cancer Innovation Trust)Genesys Capital

SUTROVAX, INC.sutrovax.comNASDAQ: PCVX

Vaxcyte is a biotech company developing vaccines to treat or prevent serious infectious diseases.

BiotechDeep TechHealthtechSouth San Francisco, US

Grant Pickering(Chief Executive Officer, Director and Co-Founder)Jeff Fairman(Vice President of Research and Co-Founder)Ashish Khanna(Executive Officer)

BoardTracy Saxton(Director)William Newell(Director)Kurt von Emster(Director)in

Co-investorsAbingworthForesite CapitalFrazier Life SciencesJanus Henderson InvestorsLongitude CapitalMedicxi+4 more

Vaxcytevaxcyte.comNASDAQ: PCVX

Vaxcyte is a clinical-stage biotechnology company developing vaccines to prevent or treat bacterial infectious diseases, including pneumococcal conjugate vaccine candidates.

BiotechHealthtech

Grant Pickering(Chief Executive Officer, Director and Co-Founder)inJeff Fairman(Vice President of Research and Co-Founder)

Co-investorsBioRock VenturesForesite CapitalFrazier Life SciencesLongitude CapitalPivotal Life SciencesRA Capital+3 more

Lqttrxlqttrx.comin𝕏✓ verified

Thryv Therapeutics is a clinical-stage biotechnology company developing selective inhibitors of serum glucocorticoid inducible kinase 1 (SGK1) for inherited cardiac arrhythmias such as Long QT Syndrome and acquired cardiometabolic diseases.

BiotechHealthtechMedical Devices

Paul F. Truex(Chairman of the Board & Chief Executive Officer)inDebra OdinkinAmy Sehnertin

Co-investorsAmzak HealthadMare BioInnovationsAlexandriaLumira Ventures

Oligonoligon.comin𝕏✓ verified

Oligon Therapeutics develops RNA-based multi-targeting drugs using its SeekR platform, which combines RNA aptamer oligo-binders with siRNA silencers into a single self-delivering molecule for precise targeting of specific cell types, including T-cells and cancer cells.

AI & Machine LearningBiotech

Spyro Mousses(Founder)in

Co-investorsFonds de solidarité FTQ

Thryvthryvtrx.comin𝕏✓ verified

Thryv Therapeutics is a clinical-stage biotech developing precision-medicine treatments for genetic arrhythmia syndromes and acquired cardiometabolic diseases using selective inhibitors of serum glucocorticoid inducible kinase 1 (SGK1).

BiotechDigital HealthMedical Devices

Paul F. Truex(Chairman of the Board & Chief Executive Officer)inDebra Odink(President & Chief Development Officer)inAmy Sehnert(Chief Medical Officer)inMatt Killeen(Chief Business Officer)in

BoardSaumya Das(Chief Scientific Advisor)

Co-investorsadMare BioInnovationsLumira VenturesAmzak HealthFonds de solidarité FTQ

Ability Pharmaabilitypharma.comin𝕏

AbilityPharma develops innovative oncology therapies that induce autophagy to treat various cancers and address unmet medical needs.

BiotechDigital HealthHealthtechMedical DevicesGirona, ES

Carles Domenech(Founder)in

Co-investorsCapital CellInveready Technology Investment Group

Aeovian Pharmaceuticalsaeovian.com

Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing selective small molecule inhibitors to treat rare genetic and age-related diseases caused by dysregulated cellular metabolism.

BiotechBerkeley, US

Allison J. Hulme(CEO & President)inJohn Kincaid(Chief Scientific Officer)inDavis Ryman(Executive Officer)inMicah Zajic(Executive Officer)inIan Massey(Executive Officer)Stelios Tzannis(Executive Officer, Director)

Co-investorsCoastCapFelix JahnFJ LabsLuma GroupSofinnova VenturesvenBio Partners+2 more

Amolyt Pharmaamolytpharma.com

Developing therapeutic peptides targeting rare endocrine diseases (past investment).

Co-investorsAndera PartnersATEM Capital FundEQT Life SciencesKurma PartnersOctalfaSofinnova Partners+3 more

Apollo Health Venturesapollo.vcin𝕏Jan 2026

Apollo is a venture capital firm that invests in life-science and biotechnology startups, combining entrepreneurial expertise with deep scientific knowledge to support early-stage companies in drug development and personalized medicine.

BiotechDeep TechHealthtechLongevity

Nils Regge(Co-Founder & General Partner)in

Co-investorsBellevue Investments & CoBLN CapitalCoastCapFelix JahnFJ LabsKfW Capital+6 more

Domain Therapeuticsdomaintherapeutics.comin𝕏

Domain Therapeutics is a clinical-stage biopharmaceutical company developing GPCR-targeting therapies to address unmet medical needs in immuno-oncology and inflammation.

BiotechDigital Health

Co-investors3B Future Health FundadMare BioInnovationsOmnes CapitalPanacea VentureSeventure Partners

enGeneengene.comin𝕏

enGene is a genetic medicine company developing drug therapies across oncology, urology, and other therapeutic areas, with a focus on patient outcomes.

BiotechMedical Devices

Co-investorsHercules Capital, Inc.Lumira Ventures

Epitopeaepitopea.comin

Epitopea is a biotech company focused on cancer immunotherapy, applying molecular biology, immunology, and computational biology to identify tumor antigens for drug and vaccine development.

AI & Machine LearningBiotechDeep TechHealthtechMontreal, CA

Claude PerreaultPierre Thibault

Co-investorsadMare BioInnovationsAdvent Life SciencesCambridge Innovation CapitalFonds de solidarité FTQ

Find Therapeuticsfindtherapeutics.comin𝕏

Find Therapeutics is a clinical-stage biopharmaceutical company developing therapies to treat demyelinating diseases, particularly multiple sclerosis and related conditions affecting myelin repair.

BiotechLongevityMedical DevicesMontreal, CA

Co-investorsadMare BioInnovations

Glycomineglycomine.comin𝕏Oct 2016

Glycomine develops therapeutics for rare diseases, many of which currently lack disease-modifying treatment options.

BiotechSan Francisco, US

Agnes Rafalko(Executive Officer, Director)inSteven Axon(Chief Executive Officer)inHicham Alaoui(Chief Scientific Officer)inRose Marino(Chief Medical Officer)inPeter McWilliams(Chief Business Officer)Geoffrey Hird(Chief Technology Officer)in

Co-investorsAdvent Life SciencesAsahi Kasei Corporate Venture CapitalChiesi VenturesMission Bay CapitalMission BiocapitalRemiges Ventures, Inc.+6 more

Phenomic AIphenomic.aiin

Phenomic AI is a biotech company developing therapies for solid tumors using a machine-learning-powered transcriptomics platform that analyzes single-cell RNA data to identify drug targets and understand tumor biology.

AI & Machine LearningBiotechDeep TechToronto, CA

Sam Cooper(Co-founder & CTO)inOren Kraus(Co-founder)in

Co-investorsCantos VenturesAV8 VenturesGarage CapitalHemi Ventures, LlcHike VenturesToronto Innovation Acceleration Partners+2 more

social mediag.coin

A URL shortcut operated by Google that directs users to official Google products and services.

Co-investorsFirst Bight VenturesSwanlaab Venture FactoryAbstract VenturesGeneral CatalystUnion Square Ventures (USV)Y Combinator

Vectivbiovectivbio.comin𝕏

Ironwood Pharmaceuticals is a gastrointestinal healthcare company developing treatments for GI diseases.

BiotechHealthtech

Co-investorsFrazier Life SciencesPfizer Venture InvestmentsSofinnova PartnersVersant Ventures

VISTERRA, INC.visterrainc.cominacquired by Otsuka

A biologics center of excellence focused on developing and delivering medicines to patients, operating as a subsidiary within the Otsuka pharmaceutical group.

AI & Machine LearningBiotechHealthtechMedical Devices

Zachary Shriver(President and Chief Executive Officer)Karthik Viswanathan(Vice President, Research)in

Co-investorsCycad Group LLCLux CapitalMRL Ventures Fund

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

CellAegis DevicesAeovianAmolytCellaegisCervelo PharmaceuticalsChlorion PharmaDalCorDalcor PharmacheuticalsEnobiaGLyPhamaGlypharmaIlkosImvKainovaKainova TherapeuticsMedicagoNeuraxonOligon Rna TherapeuticsPhemiPrecitheraProfoundSomnus TherapeuticsTargegenThryv TherapeuticsXageniscXTuit Pharmaceuticals

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.